Charles River Laboratories International (CRL) Change in Accured Expenses (2009 - 2025)

Charles River Laboratories International's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$2.6 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses rose 90.0% year-over-year to -$2.6 million; the TTM figure through Dec 2025 stood at $79.3 million (up 387.31% YoY), while the FY2025 annual figure was $79.3 million, up 387.31% from the prior year.
• Change in Accured Expenses was -$2.6 million for Q4 2025 at Charles River Laboratories International, down from $42.9 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $51.3 million in Q2 2021 to a low of -$79.8 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged $3.3 million across 5 years, with a median of $4.9 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses surged 563.47% in 2023, then plunged 188.33% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at $26.1 million in 2021, then sank by 136.14% to -$9.4 million in 2022, then slumped by 69.58% to -$16.0 million in 2023, then plunged by 60.23% to -$25.6 million in 2024, then surged by 90.0% to -$2.6 million in 2025.
• The last three Change in Accured Expenses figures came in at -$2.6 million (Q4 2025), $42.9 million (Q3 2025), and $23.7 million (Q2 2025), per Business Quant data.